Page last updated: 2024-11-03

ono 1078 and Angiolymphoid Hyperplasia with Eosinophilia

ono 1078 has been researched along with Angiolymphoid Hyperplasia with Eosinophilia in 1 studies

pranlukast: SRS-A antagonist; leukotriene D4 receptor antagonist

Angiolymphoid Hyperplasia with Eosinophilia: Solitary or multiple benign cutaneous nodules comprised of immature and mature vascular structures intermingled with endothelial cells and a varied infiltrate of eosinophils, histiocytes, lymphocytes, and mast cells.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ohtsuka, Y1
Shimizu, T1
Fujii, T1
Sato, T1
Saito, M1
Nagata, S1
Takahashi, H1
Yamashiro, Y1

Other Studies

1 other study available for ono 1078 and Angiolymphoid Hyperplasia with Eosinophilia

ArticleYear
Pranlukast regulates tumour growth by attenuating IL-4 production in Kimura disease.
    European journal of pediatrics, 2004, Volume: 163, Issue:7

    Topics: Adolescent; Angiolymphoid Hyperplasia with Eosinophilia; Child; Chromones; Enzyme-Linked Immunosorbe

2004